BioSpace News Archive

Xlear Inc. is proud to share the first results of the ongoing clinical trials using Xlear nasal spray as an adjunct treatment for people that have been exposed to Sars-cov-2.

Designed for At-Home, Business, and Institutional Use - Kits Aim to Eliminate Strain on Testing Facilities with High Frequency Testing

EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now current in its reporting showing a Yield sign. The Company targeted to become current in its reporting before the end of October and is pleased to have achieved its goal within the announced time frame. Being current now allows the majority of brokers to trade in our shares, whereas before only online brokers could buy or sell the sec

DILIsym Services, Inc., a Simulations Plus company and a leading provider of modeling and simulation software for pharmaceutical safety and efficacy, announced that the DILIsym liver safety software platform played a key role in public comments submitted to the State of California Office of Environmental Health Hazard Assessment.

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that a milestone payment of $10M from Merck has been triggered with the advancement of an ILT4 antibody, MK-4830, into a Phase 2 clinical trial.

Imagin Medical Inc. announced that further to its press release of October 22, 2020, it has closed the first US$750,000 tranche of a proposed offering of up to US$3 million aggregate principle amount Convertible Notes.

New pilot aims to help employers take a data-driven approach to addressing growing mental health crisis and its impact on employees across the country

Ozone is a natural gas composed of three atoms of oxygen and is Scientifically Proven to Kill SARS Coronavirus and Influenza; Interest is Sparked in its Ability to Combat COVID-19

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management is scheduled to participate in two upcoming investor conferences

Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced the appointment of Mark A. Doheny as Chief Financial Officer.